Scheduled IV fluids during chemo-radiation for head and neck cancer
Part of Cancer clinical trials.
This study tests whether giving IV fluids on a regular schedule during chemo-radiation helps patients with head and neck cancer stay hydrated and manage side effects better. It may reduce the need for unplanned hospital visits and improve overall well-being during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of head and neck cancer (not nasopharyngeal) that is squamous cell carcinoma, starting in the mouth, throat, voice box, or lower throat.
- You are planning to receive standard chemo-radiation with cisplatin (either once every 3 weeks or weekly).
- You are able to perform daily activities with some help (ECOG performance status 0-2).
- You do not have heart failure or a need for feeding tube or IV nutrition before starting the study.
- If you take water pills (diuretics), you must be able to safely pause them during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two cisplatin dosing schedules (weekly low-dose vs higher dose less often) given alongside radiation for certain head and neck cancers. It’s testing which schedule works well while keeping side effects manageable during planned, curative-intent radiation.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This study looks at using a special scan (F-MISO-PET) to see areas of low oxygen in head and neck cancer. The radiation dose is then customized to give higher doses to those low-oxygen areas, which may improve the chance of controlling the tumor.
This study looks at how well people swallow and how their quality of life changes during standard chemo-radiation for newly diagnosed throat (oropharyngeal) cancer. The goal is to better understand swallowing side effects so care can improve.
This trial tests a new approach that combines radiation and immunotherapy, while trying to protect your immune cells. It is for people with head and neck cancer that has not spread across the midline of the body and has not been treated yet.
This trial tests if giving less radiation than usual is safe and effective for certain head and neck cancers after initial treatment with chemotherapy and immunotherapy. It aims to reduce side effects while still controlling the cancer.
Hear when a new Squamous Cell Carcinoma of Hypopharynx trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.